Office: Matthews Hall, Room 216
Phone: (765) 496-9483
The overarching theme of Dr. Kasting’s interdisciplinary research program centers on prevention and early detection of cancer. She has worked on several topics including prevention of human papillomavirus (HPV) related cancers, early detection of hepatitis C virus (HCV) infection, and psychosocial outcomes of genetic counseling among high risk breast cancer survivors. Her HPV-related research focuses on examining multilevel barriers to HPV vaccination, including concerns about post-vaccination sexual and health behaviors (i.e., risk compensation), healthcare provider communication challenges, and broader systems-related issues surrounding healthcare provider recommendation. Additionally, she aims to reduce prevalence of liver cancer by identifying and mitigating barriers to screening for HCV infection, the cause of approximately 50% of all liver cancers in the U.S.
In addition to her work on prevention of infection-related cancers, she has also applied her quantitative analysis skills to collaborate on research projects in other cancer contexts. She worked on a study that developed and implemented a psychoeducational intervention to increase genetic counseling uptake among breast cancer survivors, and collaborated on a project examining health-related quality of life among minority breast cancer survivors with and without triple negative breast cancer. Dr. Kasting has worked across the cancer continuum and has expertise in social epidemiology, behavioral oncology, and mixed-methods research.
Postdoctoral Fellowship (2016-2018), Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
PhD in Epidemiology (2012-2016), Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN (minor: Social and Behavioral Sciences)
BS in Biology (2006-2010), Department of Biological Sciences, Purdue University, West Lafayette, IN (minors: Spanish and Psychology)
Kasting ML, Giuliano AR, Reich R, Roetzheim RG, Nelson DR, Shenkman E, Vadaparampil ST. Hepatitis C virus screening trends: Serial cross-sectional analysis of the National Health Interview Survey population, 2013-2015. Cancer Epidemiol Biomarkers Prev. 2018;27(4):1-11. doi: 10.1158/1055-9965.EPI-17-0855.
Lake P, Kasting ML, Malo TL, Giuliano AR, Vadaparampil ST. An environmental scan to examine stakeholder perspectives on HPV vaccination: A mixed methods study. Vaccine. 2018; doi: 10.1016/j.vaccine.2018.06.073.
Kasting ML, Lake P, Vadaparampil S. Physicians’ current use and preferences for male HPV vaccine-related patient education materials. Vaccine. 2017;35(20);2613-2616. doi: 10.1016/j.vaccine.2017.03.098.
Kasting ML, Scherr CL, Ali KN, Lake P, Malo TL, Johns T, Roetzheim RG, Quinn GP, Vadaparampil ST. Human papillomavirus vaccination training experience among family medicine residents and faculty. Fam Med. 2017;49(9):714-722.
Sturm L, Donahue KL, Kasting ML, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-parent conversations about human papillomavirus vaccination: An analysis of audio-recordings. J Adolesc Health. 2017;61(2):246-251. doi: 10.1016/j.jadohealth.2017.02.006.
Kasting ML, Shapiro G, Rosberger Z, Kahn JA, Zimet GD. Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research. Hum Vaccin Immunother. 2016;12(6):1435-1450. doi: 10.1080/21645515.2016.1141158.
Kasting ML, Cox AD, Cox D, Fife KH, Katz BP, Zimet GD. The effects of HIV testing advocacy messages on test acceptance: A randomized clinical trial. BMC Med. 2014;12(204). doi: 10.1186/s12916-014-0204-4.